Physician preferences for management of patients with stage IIIA NSCLC: impact of bulk of nodal disease on therapy selection.
Physician preferences for management of patients with stage IIIA NSCLC: impact of bulk of nodal disease on therapy selection. J Thorac Oncol. 2012 Feb; 7(2):365-9.